Jubilant Pharmova Limited (NSE:JUBLPHARMA)

Jubilant Pharmova Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 14, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	189,015	141,360	90,432	44,418	61,740	108,375
Market Cap Growth	56.32%	56.32%	103.60%	-28.06%	-43.03%	173.43%
Enterprise Value	205,274	161,255	117,283	70,881	82,624	136,642
Last Close Price	1194.00	895.90	566.61	273.82	375.70	654.27
PE Ratio	22.52	16.84	117.29	-	14.92	12.97
PS Ratio	2.61	1.95	1.35	0.71	1.01	1.78
PB Ratio	3.03	2.27	1.67	0.82	1.16	2.29
P/TBV Ratio	7.22	5.40	4.69	2.20	2.87	5.98
P/FCF Ratio	-	-	122.87	-	25.99	8.62
P/OCF Ratio	-	13.19	9.31	6.72	7.37	6.07
EV/Sales Ratio	2.84	2.23	1.75	1.13	1.35	2.24
EV/EBITDA Ratio	17.50	13.74	14.78	10.97	7.75	9.31
EV/EBIT Ratio	25.51	20.03	22.42	18.91	9.84	11.94
EV/FCF Ratio	-471.90	-	159.35	-	34.78	10.87
Debt / Equity Ratio	0.44	0.44	0.68	0.68	0.60	0.60
Debt / EBITDA Ratio	2.33	2.33	4.31	5.18	2.82	1.93
Debt / FCF Ratio	-	-	49.78	-	13.44	2.25
Asset Turnover	0.60	0.60	0.59	0.59	0.65	0.57
Inventory Turnover	1.91	1.91	1.73	1.54	1.23	1.02
Quick Ratio	0.92	0.92	1.18	1.26	1.34	1.64
Current Ratio	1.65	1.65	2.05	2.12	2.21	2.82
Return on Equity (ROE)	14.34%	14.34%	1.34%	-1.21%	8.21%	11.09%
Return on Assets (ROA)	4.14%	4.14%	2.88%	2.22%	5.55%	6.67%
Return on Capital (ROIC)	5.57%	5.57%	3.60%	2.67%	6.53%	7.95%
Return on Capital Employed (ROCE)	7.60%	7.60%	5.40%	4.00%	10.00%	14.50%
Earnings Yield	4.44%	5.94%	0.85%	-1.37%	6.70%	7.71%
FCF Yield	-0.23%	-0.31%	0.81%	-3.46%	3.85%	11.60%
Dividend Yield	0.42%	0.56%	0.88%	1.83%	1.33%	0.76%
Payout Ratio	9.48%	9.48%	103.50%	-	19.34%	0.18%
Buyback Yield / Dilution	0.02%	0.02%	0.18%	0.02%	0.06%	0.01%
Total Shareholder Return	0.44%	0.58%	1.06%	1.84%	1.39%	0.77%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.